U.S. Ultrasound Probe Disinfection Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Method (High-Level Disinfection, Intermediate/Low-Level Disinfection), By End Use (Hospitals & Clinics), And Segment Forecasts

U.S. Ultrasound Probe Disinfection Market Summary

The U.S. ultrasound probe disinfection market size was estimated at USD 202.04 million in 2024 and is projected to reach USD 414.94 million by 2033, growing at a CAGR of 8.38% from 2025 to 2033. The demand for ultrasound probe disinfection in the U.S. is on the rise, driven by the growing prevalence of chronic conditions such as heart disease and cancer, increasing reliance on medical imaging, a surge in product approvals, and ongoing technological advancements in probe disinfection methods.

The rising burden of chronic disorders is a significant driver for the market. The growing prevalence of cardiovascular diseases is fueling the demand for echocardiograms-ultrasound procedures of the heart that use phased array probes. According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S., underscoring the increasing dependence on cardiac ultrasound for diagnostic purposes. This substantial volume of procedures necessitates regular and thorough disinfection of ultrasound probes to prevent cross-contamination and safeguard patient health. As the use of phased array probes continues to grow in cardiac procedures, stringent disinfection protocols become even more critical. Therefore, the expanding adoption of cardiac ultrasound is expected to drive the growth of the ultrasound probe disinfection market.

Furthermore, the growing burden of health conditions like rectal cancer, prostate cancer, infertility, and heart disease is expected to significantly increase the demand for high-level disinfection solutions that can disinfect semi critical probes in the coming years. As semi-critical probes come into direct contact with mucous membranes (such as the vagina, rectum, and pharynx), they require high-level disinfection to ensure patient safety and prevent the transmission of infections.

The above data indicates the growing burden of rectal and prostate cancer in the U.S. The rising prevalence of rectal and prostate cancer in the U.S. is contributing to a growing demand for diagnostic procedures, particularly transrectal ultrasound. As the use of these procedures increases, effective disinfection of ultrasound probes becomes critically important to prevent cross-infection and maintain patient safety. Compliance with infection control standards is essential in clinical settings. Therefore, the growing cancer burden is expected to significantly boost the growth of the U.S. ultrasound probe disinfection market in the coming years.

Moreover, the rising introduction of regulations and guidelines by government bodies and healthcare organizations is anticipated to drive the demand for the ultrasound probe disinfection market. These directives encourage developing and adopting advanced disinfection products that meet updated safety standards. For example, in April 2024, the Association for the Advancement of Medical Instrumentation (AAMI) released a comprehensive guideline on the sterile processing of ultrasound probes in healthcare settings. Such documents provide clear protocols for effective probe disinfection. They are expected to accelerate market growth by guiding manufacturers in developing compliant, innovative solutions and encouraging broader adoption across clinical environments.

The growing incidence of healthcare-associated infections (HAIs) in the U.S. is expected to drive the demand for ultrasound probe disinfection solutions significantly. According to data published by the CDC in May 2024, approximately one in 31 hospital patients acquires at least one HAI on any given day. This alarming statistic underscores the urgent need for infection prevention strategies. As a result, there is increasing emphasis on the use of advanced disinfection technologies for medical devices, including ultrasound probes, to reduce cross-contamination and transmission risks. This heightened focus on infection control is anticipated to propel the growth of the U.S. ultrasound probe disinfection market in the coming years.

Key Opinion Leaders

Source: Grand View Research Analysis

Market Concentration & Characteristics

The market growth stage is high, and the pace of growth is accelerating. The U.S. ultrasound probe disinfection market is characterized by high growth due to the rising burden of chronic diseases, increasing focus on infection controls, supportive government and regulatory initiatives, and the growing launches of novel products.

Industry players are innovating their offerings by integrating novel technologies in probe disinfection instruments. Emerging technologies within the ultrasound probe disinfection space include chemical-free UV-C disinfection, automated disinfection systems, and digital traceability & infection control management systems. Industry participants are actively designing automated disinfection solutions to fulfill this growing demand, with regulatory bodies encouraging market expansion through timely authorizations of innovative products. For instance, in June 2023, CS Medical introduced the FDA-approved Ethos Automated Ultrasound Probe Cleaner Disinfector, the first North American system to integrate high-level disinfection (HLD) and automated cleaning for surface and endocavity probes.

In the U.S., ultrasound probe disinfection products are regulated primarily by the Food and Drug Administration (FDA) as medical devices. FDA oversees the marketing authorization of these products, including instruments and consumables. For example, in October 2023, the Germitec Chronos, a UV radiation disinfection chamber designed for high-level disinfection of transvaginal, external, and transrectal ultrasound probes, received De Novo approval from the U.S. FDA.

Table 1 Some of the FDA-cleared sterilants and high level disinfectants used for probe disinfection are mentioned below:

Source: Food and Drug Administration (U.S. FDA)

Industry players are increasingly focusing on expanding their product reach within the U.S. market through strategic distribution partnerships with OEMs, e-commerce platforms, and distributors. For example, in September 2022, Parker Labs partnered with Tristel to exclusively manufacture and distribute Tristel DUO disinfectant foam for ultrasound transducer and medical surface disinfection in the U.S. These partnerships are expected to play a key role in driving the U.S. ultrasound probe disinfection market growth.

Method Insights

The intermediate level disinfection/low-level disinfection segment accounted for the largest share of the market in 2024. The ease of use, lower cost, and availability of disinfectant wipes and sprays support the growth of the intermediate-level or low-level disinfection segment. Additionally, increasing adoption in outpatient settings and routine diagnostic procedures continues to drive demand for this disinfection method.

The high-level disinfection segment is projected to be the fastest-growing segment in the U.S. ultrasound probe disinfection market from 2025 to 2033. This growth is driven by the increasing availability of FDA-approved, cost-effective high-level disinfectants tailored for use with ultrasound probes. For example, in June 2023, the U.S. FDA granted clearance for Tristel ULT, a novel disinfecting foam approved for high-level disinfection of ultrasound probes used in body cavities and skin surfaces. Such approvals are expected to support segment expansion significantly.

End-use Insights

The hospitals & clinics segment dominated the market in 2024, accounting for the largest share of 43.46%. The high procedure volume, availability of advanced equipment, trained healthcare staff, and strong patient preference for hospital-based care drive this dominance. Additionally, strict infection control protocols and higher adoption of disinfection technologies further support growth in this segment.

The diagnostic imaging centers segment is projected to register the highest CAGR from 2025 to 2033. This growth is driven by increasing investment in diagnostic imaging infrastructure, a high volume of ultrasound procedures, and the rising demand for outpatient imaging services. Factors such as faster patient turnaround, cost-effective services, and growing awareness of infection control practices are further expected to boost segment growth.

Product Insights

The instruments segment dominated the market, accounting for 42.66% of total revenue in 2024. It is also anticipated to grow fastest over the forecast period. The availability of various advanced instruments, including automated reprocessors, UV-C disinfectors, manual reprocessors/soaking stations, and ultrasound probe storage cabinets, drives this growth. Additionally, increasing FDA approvals for innovative disinfection instruments are expected to propel segment growth further. For example, in June 2023, CS Medical received U.S. FDA clearance for its new Class II medical device, the Ethos Automated Ultrasound Probe Cleaner Disinfector. Such approvals for advanced disinfection instruments are expected to boost the segment’s expansion significantly.

The service segment is expected to grow significantly in the U.S. ultrasound probe disinfection market. This growth is driven by the increasing adoption of disinfection services tailored to meet the rising demands of healthcare facilities, ensuring compliance with infection control regulations and enhancing patient safety.

Key U.S. Ultrasound Probe Disinfection Companies Insights

Key players operating in the U.S. ultrasound probe disinfection market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In February 2025, Germitec announced the successful completion of a USD 30 million financing round. This funding will support the company's efforts to accelerate growth in the U.S. market and further advance innovations in UV-C infection prevention technologies.

• In November 2024, Nanosonics announced that the trophon Wireless Ultrasound Probe Holder is available in the U.S.It is specifically designed for HLD of wireless ultrasound probes.

• In September 2024, the U.S. FDA granted its first-ever De Novo classification for an ultraviolet radiation disinfection chamber device to Germitec’s Chronos. This chemical-free UV-C High-level Disinfection (HLD) device is designed to disinfect endocavitary and external ultrasound probes.

U.S. Ultrasound Probe Disinfection Market Report Scope

U.S. Ultrasound Probe Disinfection Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ultrasound probe disinfection market report based on product, method, and end-use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Instruments

    • Automated Reprocessors

    • UV-C Disinfectors

    • Manual Reprocessors/Soaking Stations

    • Ultrasound Probe Storage Cabinets

  • Consumables

    • Consumables, By Formulations

      • Disinfectant Liquids

      • Disinfectant Wipes

      • Disinfectant Sprays

    • Consumables, By Detergent

      • Enzymatic Detergents

      • Non-enzymatic Detergents

  • Service

• Method Outlook (Revenue, USD Million, 2021 - 2033)

  • High-Level Disinfection

  • Intermediate Level Disinfection/Low-Level Disinfection

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Clinics

  • Diagnostic Imaging Centers

  • Others